Wave Life Sciences Ltd. (WVE) NASDAQ
7.26
+0.08(+1.11%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
7.26
+0.08(+1.11%)
Currency In USD
| Market Cap | 2.87B |
| Enterprise Value | 2.28B |
| P/E Ratio | -6.4 |
| PEG Ratio | 0.1 |
| Price/Sales Ratio | 31.99 |
| Price/Book Ratio | 2.49 |
| Enterprise/Revenue | 18.31 |
| Enterprise/EBITDA | -3.9 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -4.78 |
| Operating Margin | -5.04 |
| Return On Assets | -0.32 |
| Return On Equity | -0.85 |
| Revenue | 42.73M |
| Revenue/Share | 0.24 |
| Gross Profit | 33.88M |
| EBITDA | -195.53M |
| Net Income | -204.38M |
| Diluted EPS | -1.21 |
| Total Cash | 602.07M |
| Total Cash/Share | 3.34 |
| Total Debt | 17.77M |
| Total Debt/Equity | 0.03 |
| Current Ratio | 6.47 |
| Book Value Per Share | 2.92 |
| 52-Week Change | 21 |
| 52-Week High | 21.73 |
| 52-Week Low | 5.02 |
| Moving Average 50 Days | 11.67 |
| Moving Average 200 Days | 10.2 |
| Average Volume | 4.11M |
| Shares Outstanding | 188.25M |
| % Held by Institutions | 108.95 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |